vaccine trial One-dose Pfizer is not happening and here's why Kaiser explores what the Pfizer vaccine trial data say about a one-dose treatment.
vaccine effectiveness Cutting infection rate by half is not the same as protecting half the people from infection Kaiser explains what 50% vaccine efficacy actually means, and it's not what you think.
Covid-19 The Swedish mirage: the verdict is already written Kaiser asks whether we need more time to evaluate Sweden's approach to coronavirus.
Behavior I don't like the term herd immunity Kaiser explains why the term "herd immunity" is problematic
Excel Dr. Backlog jumps the pond Kaiser investigates the official reason for U.K. under-reporting of coronavirus cases.